iBio, Inc.
IBIO
$4.57
-$0.2896-5.96%
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -2.11% | 14.61% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 12.49% | 14.56% | |||
| Operating Income | -7.62% | -20.45% | |||
| Income Before Tax | -9.40% | -22.89% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -9.40% | -22.89% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -9.40% | 48.71% | |||
| EBIT | -7.62% | -20.45% | |||
| EBITDA | -7.95% | -22.97% | |||
| EPS Basic | -3.42% | 49.01% | |||
| Normalized Basic EPS | -3.43% | -22.17% | |||
| EPS Diluted | -3.42% | 49.01% | |||
| Normalized Diluted EPS | -3.43% | -22.17% | |||
| Average Basic Shares Outstanding | 5.78% | 0.58% | |||
| Average Diluted Shares Outstanding | 5.78% | 0.58% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
